生命早期全氟和多氟烷基物质暴露与儿童肠道炎症相关:三项出生队列分析
该研究在三个出生队列中检测生命早期样本中的全氟和多氟烷基物质(PFAS),并纵向测量子代粪便钙卫蛋白。结果显示PFAS混合物水平较高与1至6岁及儿童晚期粪便钙卫蛋白升高相关,母亲炎症性肠病者的某些PFAS代谢物水平更高且对钙卫蛋白贡献最大。
要点
- 生命早期PFAS暴露与儿童期粪便钙卫蛋白升高相关
- 母亲IBD者子代某些PFAS代谢物水平更高且贡献最大
- 需关注生命早期PFAS暴露对肠道炎症的潜在影响
核心结论
- 生命早期样本中可检测到PFAS,提示暴露于该脆弱期,且与三个出生队列中儿童期粪便钙卫蛋白升高相关。
研究设计与样本
- 在三个出生队列中,对母婴二元组的生命早期样本进行非靶向PFAS分析,包括子代干血斑(n=84)和脐带血(n=93)来自纽约两个前瞻性出生队列(母亲有或无IBD),以及墨西哥城出生队列的孕期母体血清(n=14)。
- 纵向测量子代粪便钙卫蛋白,并使用协变量调整的加权分位数和回归模型估计PFAS与粪便钙卫蛋白的关联。
主要发现
- 在干血斑和脐带血分析中,PFAS混合物水平较高与1至6岁粪便钙卫蛋白升高相关(6岁时log转换粪便钙卫蛋白每十分位增加的协变量调整β估计分别为0.44 [95%CI 0.18-0.70]和0.69 [95%CI 0.53-0.85])。
- 母体血清中PFAS混合物水平较高与儿童晚期粪便钙卫蛋白升高相关(β=0.19;95%CI 0.05-0.33)。
- 与无母体IBD的母婴二元组相比,有母体IBD者干血斑中全氟-1-辛烷磺酰胺乙酸和脐带血中3-全氟己基-2-羟基丙基丙烯酸酯水平更高,且这些PFAS代谢物也是子代粪便钙卫蛋白的主要贡献者。
临床怎么用
- 对于有IBD家族史(尤其母亲IBD)的儿童,可关注生命早期PFAS暴露作为肠道炎症的潜在风险因素。
- 粪便钙卫蛋白可作为儿童肠道炎症的生物标志物,用于监测PFAS暴露相关风险。
局限性
- 样本量较小(干血斑n=84,脐带血n=93,母体血清n=14),可能限制统计效能和普遍性。
- 研究为观察性设计,无法确立因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Early life exposures shape intestinal and immune development and later risk of inflammatory bowel disease. Per- and polyfluoroalkyl substances, or forever chemicals, are associated with intestinal inflammation and inflammatory bowel disease. However, the impact of early life per- and polyfluoroalkyl substances exposure on later intestinal inflammation is not known. METHODS: We conducted untargeted per- and polyfluoroalkyl substances analyses in early life samples from mother-offspring dyads across 3 cohorts. These included dried blood spots from offspring (n = 84) and cord blood (n = 93) from 2 prospective birth cohorts of mothers with and without inflammatory bowel disease in New York, New York, and maternal serum during pregnancy (n = 14) from a birth cohort in Mexico City, Mexico. Fecal calprotectin, a biomarker of intestinal inflammation, was measured longitudinally in offspring stool. Covariate-adjusted weighted quantile sum regression models were used to estimate associations between per- and polyfluoroalkyl substances and fecal calprotectin. RESULTS: Per- and polyfluoroalkyl substances metabolites were detected across all sample types. Higher levels of per- and polyfluoroalkyl substances mixtures were associated with higher fecal calprotectin between 1 and 6 years of age in both dried blood spot and cord blood analyses (covariate-adjusted β estimates for change in log-transformed fecal calprotectin at age 6 years per decile increase in the per- and polyfluoroalkyl substances mixture was 0.44 [95% confidence interval, 0.18-0.70] and 0.69 [95% confidence interval, 0.53-0.85], respectively) Similarly, higher levels of per- and polyfluoroalkyl substances mixtures in maternal serum were associated with higher fecal calprotectin in late childhood (β, 0.19; 95% confidence interval, 0.05-0.33). Compared with mother-offspring dyads without maternal inflammatory bowel disease, those with maternal inflammatory bowel disease were more likely to have higher perfluoro-1-octane sulfonamide acetic acid and 3-perfluorohexyl-2-hydroxypropyl acrylate levels in dried blood spots and cord blood, respectively; these per- and polyfluoroalkyl substances metabolites were also the top contributors to offspring fecal calprotectin. CONCLUSIONS: Per- and polyfluoroalkyl substances chemicals are detectable in early life samples, indicating exposure during this period of vulnerability, and are associated with higher fecal calprotectin in childhood across 3 birth cohorts.
引用
- Midya V, Maroli AS, Picker M, et al. Per- and Polyfluoroalkyl Substances in Early Life Are Associated With Childhood Intestinal Inflammation: Analyses of Three Birth Cohorts. Clin Gastroenterol Hepatol. 2026. PMID: 42431496. doi:10.1016/j.cgh.2026.07.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。